Drug Approval Challenges
Andrew discusses the potential of MDMA in treating PTSD and stress disorders, emphasizing the importance of proper therapeutic support. He reflects on the FDA's rejection of certain treatments, urging a scientific approach to understanding and addressing the reasons behind such decisions. Trust in quality supplements is highlighted, with a recommendation for sleep packs that contain evidence-based ingredients for better rest.In this clip
From this podcast
Modern Wisdom
The New Science Of Longevity, Resilience & Breaking Bad Habits - Dr Andrew Huberman (4K)
Related Questions